NCR2 and cancer: Hypoxia represses NK activation receptors, including NKp46, NKp44, NKp30, and NKG2D, preventing NK cell-mediated cancer cell killing, while enhances the level of MHC class I molecules on cancer cells and their binding to inhibitory receptors on NK cells.